Free tool
Healthcare stocks
We cover 47 companies in the Healthcare sector. The median market value in the group is $2.05B. Across the group, the median move over the past trading day is 0.00%. 36% of the 45 with a 200-day average trade above it. Price change over the past year runs from −77.4% to +35.7% across the middle 80 percent of the group, with a median of −19.2%.
Other lists in this group
Table
47 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% | Aug 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| 3391.T | Tsuruha Holdings Inc. | 2,379.00 JPY | −8.08% | −16.55% | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 387,000.00 KRW | +9.79% | −45.87% | +15.35% | Oct 23, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% | Sep 1, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% | Aug 27, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,559.00 JPY | −6.35% | −14.64% | −26.59% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% | Sep 17, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,682.50 JPY | −11.53% | −26.40% | −28.60% | Oct 8, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% | Sep 23, 2026 |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% | Oct 1, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% | Aug 27, 2026 |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% | Aug 27, 2026 |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% | Aug 27, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | 38,100.00 KRW | +17.23% | −20.62% | −20.29% | Oct 26, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| NNOX | Nano-X Imaging Ltd. | $0.88 | −0.25% | −69.05% | −77.77% | Sep 9, 2026 |
| CSBR | Champions Oncology, Inc. | $4.92 | −11.03% | −26.13% | −25.45% | Sep 14, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% | Aug 27, 2026 |
| HYFT | MindWalk Holdings Corp. | $1.43 | +5.15% | −29.21% | −46.04% | Sep 14, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | 7.78 NOK | −11.59% | −22.04% | −4.19% | Aug 27, 2026 |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% | Oct 22, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% | Oct 22, 2026 |
| POCI | Precision Optics Corporation, Inc. | $4.35 | −2.03% | +2.35% | −12.30% | Sep 28, 2026 |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% | Aug 27, 2026 |
| LITS | Lite Strategy, Inc. | $0.99 | +2.38% | −35.51% | −80.75% | Sep 28, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% | Sep 10, 2026 |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −42.11% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | 3.55 NOK | +3.20% | −14.46% | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% | Sep 15, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% | Sep 28, 2026 |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% | Sep 23, 2026 |
| AVNT.TO | Avant Brands Inc. | 0.60 CAD | +3.45% | −34.07% | −28.57% | Oct 15, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $0.31 | −6.25% | −79.22% | −89.43% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.